{
    "2021-12-16": [
        [
            {
                "time": "",
                "orginal_text": "龙头股突然躺倒？高瓴抛售躲过大跌，公募明星基金分歧显现",
                "features": {
                    "keywords": [
                        "龙头股",
                        "高瓴",
                        "抛售",
                        "大跌",
                        "公募基金",
                        "分歧"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "股票"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "年末盘点 | 2021募资之王：最能“忽悠”LP的投资人",
                "features": {
                    "keywords": [
                        "募资",
                        "投资人",
                        "LP"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "投资"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "北向资金追平年内最长净买入记录，山西汾酒净卖出额创历史新高",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "山西汾酒",
                        "净卖出"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "恒指收涨0.23%，医药股强势反弹、煤炭股爆发",
                "features": {
                    "keywords": [
                        "恒指",
                        "医药股",
                        "煤炭股",
                        "反弹",
                        "爆发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "煤炭"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "外资巨头增持A股核心资产，这些股被大幅增持！风格要变了？",
                "features": {
                    "keywords": [
                        "外资",
                        "A股",
                        "核心资产",
                        "增持",
                        "风格变化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "股票"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "瑞银：维持泰格医药“买入”评级，目标价降29.6%至173.82港元",
                "features": {
                    "keywords": [
                        "瑞银",
                        "泰格医药",
                        "买入",
                        "目标价下降"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "瑞银：维持泰格医药(03347)“买入”评级 目标价降29.6%至173.82港元",
                "features": {
                    "keywords": [
                        "瑞银",
                        "泰格医药",
                        "买入",
                        "目标价下降"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "[异动股]泰格医药(03347.HK)涨4.36%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德跌停 “要命”，“医药女神”葛兰旗下基金单日大跌4.24%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "跌停",
                        "葛兰",
                        "基金",
                        "大跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "每日理财观察: 中国11月宏观经济数据出炉",
                "features": {
                    "keywords": [
                        "宏观经济",
                        "数据出炉"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "经济"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "22股获券商买入评级，康泰生物目标涨幅达97.29%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "康泰生物",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}